首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   2279736篇
  免费   168278篇
  国内免费   3682篇
耳鼻咽喉   33520篇
儿科学   77711篇
妇产科学   65232篇
基础医学   328644篇
口腔科学   63391篇
临床医学   198096篇
内科学   447030篇
皮肤病学   48988篇
神经病学   177829篇
特种医学   90031篇
外国民族医学   973篇
外科学   350821篇
综合类   49101篇
现状与发展   1篇
一般理论   632篇
预防医学   171234篇
眼科学   51964篇
药学   171499篇
  3篇
中国医学   4406篇
肿瘤学   120590篇
  2018年   22364篇
  2016年   18848篇
  2015年   21462篇
  2014年   29852篇
  2013年   45698篇
  2012年   62578篇
  2011年   66724篇
  2010年   39747篇
  2009年   37699篇
  2008年   64208篇
  2007年   69262篇
  2006年   69924篇
  2005年   68313篇
  2004年   66381篇
  2003年   64234篇
  2002年   63172篇
  2001年   105782篇
  2000年   109237篇
  1999年   92980篇
  1998年   26156篇
  1997年   23504篇
  1996年   23887篇
  1995年   22645篇
  1994年   21447篇
  1993年   19870篇
  1992年   74468篇
  1991年   73154篇
  1990年   71752篇
  1989年   69009篇
  1988年   64024篇
  1987年   62924篇
  1986年   59292篇
  1985年   56811篇
  1984年   42684篇
  1983年   36395篇
  1982年   21565篇
  1981年   19346篇
  1980年   17748篇
  1979年   39333篇
  1978年   27500篇
  1977年   23644篇
  1976年   22269篇
  1975年   24258篇
  1974年   28502篇
  1973年   27456篇
  1972年   25783篇
  1971年   23734篇
  1970年   22270篇
  1969年   20864篇
  1968年   19388篇
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
101.
To determine the protective effect of aloe-emodin (AE) from high glucose induced toxicity in RIN-5F (pancreatic β-cell) cell and restoration of its function was analyzed. RIN-5F cells have been cultured in high glucose (25 mM glucose) condition, with and without AE treatment. RIN-5F cells cultured in high glucose decreased cell viability and increased ROS levels after 48 hr compared with standard medium (5.5 mM glucose). Glucotoxicity was confirmed by significantly increased ROS production, increased pro-inflammatory (IFN-γ, IL-1β,) & decreased anti-inflammatory (IL-6&IL-10) cytokine levels, increased DNA fragmentation. In addition, we found increased Bax, caspase 3, Fadd, and Fas and significantly reduced Bcl-2 expression after 48 hr. RIN-5F treated with both high glucose and AE (20 μM) decreased ROS generation and prevent RIN-5F cell from glucotoxicity. In addition, AE treated cells cultured in high glucose were transferred to standard medium, normal responsiveness to glucose was restored within 8hr and normal basal insulin release within 24 hr was achieved when compared to high glucose.  相似文献   
102.
103.
104.
105.
106.
107.
Women with pre-eclampsia have an increased risk of cardiovascular disease later in life. The aim of the study was to establish the presence and pattern of arterial stiffness in women previously with pre-eclampsia from a semi-rural region of South Africa. This was a prospective longitudinal study which involved 36 previously pre-eclamptic women and 86 non-pregnant controls (NPC) who had a past history of non-complicated pregnancy. Maternal wave reflection (augmentation index) and carotid-femoral pulse wave velocity were assessed noninvasively, using applanation tonometry with the SphygmoCor device. Endothelial function was assessed by EndoPAT 2000 device; pneumatic probes were fitted to the index fingers; induced flow-mediated reactive hyperemia; the ratio of the readings before and after occlusion was then used to calculate the score, the reactive hyperemia index (RHI) as a measure of endothelial function.

Pulse wave velocity remained significantly higher in previously pre-eclamptic women than non-pregnant controls up to three months after delivery (p < 0.05), then it reduced to nonsignificant values. All blood pressure indices (central and brachial pressures), were higher in previously pre-eclamptic women as compared to nonpregnant controls up to one year postpartum.

Regional (aortic) arterial stiffness, though it persists for some time after delivery, is transitory in previously pre-eclamptic women from the rural Africa setting. However, their increase blood pressure is an indication of compromised arterial compliance in women previously with pre-eclampsia.  相似文献   

108.
109.
110.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号